On May 16, 2025, Qingdao Baiyang Pharmaceutical Co., Ltd.(referred to as "Qingdao Baiyang Pharmaceutical"), a subsidiary of Baiyang Pharmaceutical (301015.SZ), held a relocation ceremony for the third phase of the construction project.

On May 14, Zhao Haozhi, Deputy Secretary of the Qingdao Municipal Party Committee and Mayor, led responsible comrades from relevant municipal departments to Jimo District to conduct on-site research on industrial economic operations and key project construction. He emphasized that it is necessary to thoroughly study and implement General Secretary Xi Jinping's important instructions and requirements for the work of Shandong and Qingdao, persist in promoting industrial innovation through scientific and technological innovation, vigorously develop advanced manufacturing, and promote the construction of key industrial chains to continuously achieve new breakthroughs...

Recently, Qingdao Baiyang Pharmaceutical Co., Ltd.(hereinafter referred to as "Qingdao Baiyang Pharmaceutical"), a subsidiary of Shanghai Baiyang Pharmaceutical Co., Ltd., received an official notice from the U.S. Food and Drug Administration (hereinafter referred to as FDA) that Qingdao Baiyang Pharmaceutical issued an NAI (No Action Indicated, no need to take rectification) zero "483" defects...

On September 28, 2023, Qingdao Baiyang Pharmaceutical Co., Ltd.(hereinafter referred to as "Qingdao Baiyang Pharmaceutical"), a subsidiary of Shanghai Baiyang Pharmaceutical Co., Ltd., held a groundbreaking ceremony for the third-phase construction project of the production workshop and supporting projects. Relevant leaders of Jimo District Government of Qingdao City and relevant leaders of Provincial Food and Drug Administration...